(3S,4S)-3-methyl-8-[7-[(4S)-4-methyl-6-(1,2,4-oxadiazol-3-yl)-3,4-dihydro-2H-1,5-naphthyridin-1-yl]-5H-pyrrolo[3,4-b]pyrazin-3-yl]-2-oxa-8-azaspiro[4.5]decan-4-amine

C26H31N9O2 — CID 161178845

IUPAC(3S,4S)-3-methyl-8-[7-[(4S)-4-methyl-6-(1,2,4-oxadiazol-3-yl)-3,4-dihydro-2H-1,5-naphthyridin-1-yl]-5H-pyrrolo[3,4-b]pyrazin-3-yl]-2-oxa-8-azaspiro[4.5]decan-4-amine
SMILESC[C@@H]1OCC2(CCN(c3cnc4c(n3)CN=C4N3CC[C@H](C)c4nc(-c5ncon5)ccc43)CC2)[C@@H]1N
InChIInChI=1S/C26H31N9O2/c1-15-5-8-35(19-4-3-17(32-21(15)19)24-30-14-37-33-24)25-22-18(11-29-25)31-20(12-28-22)34-9-6-26(7-10-34)13-36-16(2)23(26)27/h3-4,12,14-16,23H,5-11,13,27H2,1-2H3/t15-,16-,23+/m0/s1
InChIKeyIMPVQKYYNAZASV-PBPSECFOSA-N
MW501.60 g/mol
LogP2.53
Rot. Bonds2

About (3S,4S)-3-methyl-8-[7-[(4S)-4-methyl-6-(1,2,4-oxadiazol-3-yl)-3,4-dihydro-2H-1,5-naphthyridin-1-yl]-5H-pyrrolo[3,4-b]pyrazin-3-yl]-2-oxa-8-azaspiro[4.5]decan-4-amine

(3S,4S)-3-methyl-8-[7-[(4S)-4-methyl-6-(1,2,4-oxadiazol-3-yl)-3,4-dihydro-2H-1,5-naphthyridin-1-yl]-5H-pyrrolo[3,4-b]pyrazin-3-yl]-2-oxa-8-azaspiro[4.5]decan-4-amine (PubChem CID 161178845) has the molecular formula C26H31N9O2 and a molecular weight of 501.60 g/mol. Its IUPAC name is (3S,4S)-3-methyl-8-[7-[(4S)-4-methyl-6-(1,2,4-oxadiazol-3-yl)-3,4-dihydro-2H-1,5-naphthyridin-1-yl]-5H-pyrrolo[3,4-b]pyrazin-3-yl]-2-oxa-8-azaspiro[4.5]decan-4-amine.

Molecular Properties

Compound Name(3S,4S)-3-methyl-8-[7-[(4S)-4-methyl-6-(1,2,4-oxadiazol-3-yl)-3,4-dihydro-2H-1,5-naphthyridin-1-yl]-5H-pyrrolo[3,4-b]pyrazin-3-yl]-2-oxa-8-azaspiro[4.5]decan-4-amine
PubChem CID161178845
Molecular FormulaC26H31N9O2
Molecular Weight501.60 g/mol
Exact Mass501.26
IUPAC Name(3S,4S)-3-methyl-8-[7-[(4S)-4-methyl-6-(1,2,4-oxadiazol-3-yl)-3,4-dihydro-2H-1,5-naphthyridin-1-yl]-5H-pyrrolo[3,4-b]pyrazin-3-yl]-2-oxa-8-azaspiro[4.5]decan-4-amine
SMILESC[C@@H]1OCC2(CCN(c3cnc4c(n3)CN=C4N3CC[C@H](C)c4nc(-c5ncon5)ccc43)CC2)[C@@H]1N
InChIInChI=1S/C26H31N9O2/c1-15-5-8-35(19-4-3-17(32-21(15)19)24-30-14-37-33-24)25-22-18(11-29-25)31-20(12-28-22)34-9-6-26(7-10-34)13-36-16(2)23(26)27/h3-4,12,14-16,23H,5-11,13,27H2,1-2H3/t15-,16-,23+/m0/s1
InChIKeyIMPVQKYYNAZASV-PBPSECFOSA-N
XLogP2.53
TPSA131.68 Ų
H-Bond Donors1
H-Bond Acceptors11
Rotatable Bonds2
Heavy Atoms37
Complexity

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 500501.60
LogP ≤ 52.53
H-Bond Donors ≤ 51
H-Bond Acceptors ≤ 1011

Analyze (3S,4S)-3-methyl-8-[7-[(4S)-4-methyl-6-(1,2,4-oxadiazol-3-yl)-3,4-dihydro-2H-1,5-naphthyridin-1-yl]-5H-pyrrolo[3,4-b]pyrazin-3-yl]-2-oxa-8-azaspiro[4.5]decan-4-amine with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of (3S,4S)-3-methyl-8-[7-[(4S)-4-methyl-6-(1,2,4-oxadiazol-3-yl)-3,4-dihydro-2H-1,5-naphthyridin-1-yl]-5H-pyrrolo[3,4-b]pyrazin-3-yl]-2-oxa-8-azaspiro[4.5]decan-4-amine?
The IUPAC name of (3S,4S)-3-methyl-8-[7-[(4S)-4-methyl-6-(1,2,4-oxadiazol-3-yl)-3,4-dihydro-2H-1,5-naphthyridin-1-yl]-5H-pyrrolo[3,4-b]pyrazin-3-yl]-2-oxa-8-azaspiro[4.5]decan-4-amine (CID 161178845) is (3S,4S)-3-methyl-8-[7-[(4S)-4-methyl-6-(1,2,4-oxadiazol-3-yl)-3,4-dihydro-2H-1,5-naphthyridin-1-yl]-5H-pyrrolo[3,4-b]pyrazin-3-yl]-2-oxa-8-azaspiro[4.5]decan-4-amine.
What is the SMILES notation for (3S,4S)-3-methyl-8-[7-[(4S)-4-methyl-6-(1,2,4-oxadiazol-3-yl)-3,4-dihydro-2H-1,5-naphthyridin-1-yl]-5H-pyrrolo[3,4-b]pyrazin-3-yl]-2-oxa-8-azaspiro[4.5]decan-4-amine?
The canonical SMILES for (3S,4S)-3-methyl-8-[7-[(4S)-4-methyl-6-(1,2,4-oxadiazol-3-yl)-3,4-dihydro-2H-1,5-naphthyridin-1-yl]-5H-pyrrolo[3,4-b]pyrazin-3-yl]-2-oxa-8-azaspiro[4.5]decan-4-amine is C[C@@H]1OCC2(CCN(c3cnc4c(n3)CN=C4N3CC[C@H](C)c4nc(-c5ncon5)ccc43)CC2)[C@@H]1N.
What is the InChIKey of (3S,4S)-3-methyl-8-[7-[(4S)-4-methyl-6-(1,2,4-oxadiazol-3-yl)-3,4-dihydro-2H-1,5-naphthyridin-1-yl]-5H-pyrrolo[3,4-b]pyrazin-3-yl]-2-oxa-8-azaspiro[4.5]decan-4-amine?
The InChIKey is IMPVQKYYNAZASV-PBPSECFOSA-N. The full InChI is InChI=1S/C26H31N9O2/c1-15-5-8-35(19-4-3-17(32-21(15)19)24-30-14-37-33-24)25-22-18(11-29-25)31-20(12-28-22)34-9-6-26(7-10-34)13-36-16(2)23(26)27/h3-4,12,14-16,23H,5-11,13,27H2,1-2H3/t15-,16-,23+/m0/s1.
What are the key properties of (3S,4S)-3-methyl-8-[7-[(4S)-4-methyl-6-(1,2,4-oxadiazol-3-yl)-3,4-dihydro-2H-1,5-naphthyridin-1-yl]-5H-pyrrolo[3,4-b]pyrazin-3-yl]-2-oxa-8-azaspiro[4.5]decan-4-amine?
(3S,4S)-3-methyl-8-[7-[(4S)-4-methyl-6-(1,2,4-oxadiazol-3-yl)-3,4-dihydro-2H-1,5-naphthyridin-1-yl]-5H-pyrrolo[3,4-b]pyrazin-3-yl]-2-oxa-8-azaspiro[4.5]decan-4-amine has a molecular weight of 501.60 g/mol, XLogP of 2.53, 2 rotatable bonds, 1 hydrogen bond donors, and 11 hydrogen bond acceptors.
Where does this data come from?
All data for (3S,4S)-3-methyl-8-[7-[(4S)-4-methyl-6-(1,2,4-oxadiazol-3-yl)-3,4-dihydro-2H-1,5-naphthyridin-1-yl]-5H-pyrrolo[3,4-b]pyrazin-3-yl]-2-oxa-8-azaspiro[4.5]decan-4-amine is sourced from PubChem (CID 161178845), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).